drugset / Trial / NCT05900531
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multiple dose study to evaluate the safety, tolerability, PK, and PD of K-757 alone, in combination with sitagliptin, or in combination with K-833.
Timeline
- Start
- 2022-09-21
- Primary completion
- 2023-05-03
- Completion
- 2023-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | K-757 | Unknown | — | Oral |
| Subject | K-833 | Unknown | — | Oral |
| Subject | Sitagliptin | Small molecule | — | Oral |